SEC
|
Epstein David R
|
CEO
|
|
-11K
|
$213.01
|
-$2.26M
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-8.8K
|
$213.32
|
-$1.87M
|
|
SEC
|
DANSEY ROGER D
|
President, R&D & CMO
|
|
-71
|
$206.50
|
-$14.66K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-80
|
$206.50
|
-$16.52K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-64
|
$206.50
|
-$13.22K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial U.S.
|
|
-45
|
$206.50
|
-$9.29K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-80
|
$206.50
|
-$16.52K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-8.8K
|
$205.76
|
-$1.81M
|
|
SEC
|
DANSEY ROGER D
|
President, R&D & CMO
|
|
-4K
|
$206.97
|
-$833.88K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-1.8K
|
$206.97
|
-$371.51K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-1.9K
|
$206.97
|
-$391.79K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial U.S.
|
|
-555
|
$206.97
|
-$114.87K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-2.1K
|
$206.97
|
-$439.19K
|
|
SEC
|
DANSEY ROGER D
|
President, R&D & CMO
|
|
-1K
|
$206.00
|
-$209.30K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-371
|
$206.00
|
-$76.43K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-405
|
$206.00
|
-$83.43K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial U.S.
|
|
-438
|
$206.00
|
-$90.23K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-485
|
$206.00
|
-$99.91K
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
-4.9K
|
$209.08
|
-$1.03M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial U.S.
|
|
-708
|
$192.46
|
-$136.26K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-16K
|
$195.29
|
-$3.17M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial U.S.
|
|
-349
|
$189.86
|
-$66.26K
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
-1.9K
|
$200.02
|
-$372.84K
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
-27K
|
$200.07
|
-$5.41M
|
|
SEC
|
DANSEY ROGER D
|
President, R&D & CMO
|
|
-10K
|
$205.95
|
-$2.06M
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-5K
|
$205.86
|
-$1.03M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-55K
|
$204.58
|
-$11.32M
|
|
SEC
|
DANSEY ROGER D
|
President, R&D & CMO
|
|
-333
|
$205.86
|
-$68.55K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-174
|
$205.86
|
-$35.82K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial U.S.
|
|
-133
|
$205.86
|
-$27.38K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-243
|
$205.86
|
-$50.02K
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
-31K
|
$201.61
|
-$6.25M
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-5K
|
$199.90
|
-$999.50K
|
|
SEC
|
DANSEY ROGER D
|
President, R&D & CMO
|
|
-10K
|
$199.81
|
-$2.00M
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
-3.6K
|
$200.05
|
-$720.78K
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
-27K
|
$200.35
|
-$5.49M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-43K
|
$176.61
|
-$7.56M
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-16K
|
$177.21
|
-$2.87M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-20K
|
$182.53
|
-$3.65M
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-5K
|
$155.00
|
-$775.00K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-40K
|
$160.00
|
-$6.39M
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
+8.8K
|
$36.70
|
+$321.13K
|
|
SEC
|
DANSEY ROGER D
|
President, R&D & CMO
|
|
-783
|
$138.52
|
-$108.46K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-578
|
$130.71
|
-$75.55K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial U.S.
|
|
-1.1K
|
$127.63
|
-$144.09K
|
|
SEC
|
Simonian Nancy A
|
N/A
|
|
+8.8K
|
$36.70
|
+$321.13K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
+1.3K
|
$76.86
|
+$99.99K
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-7.5K
|
$129.10
|
-$968.25K
|
|
SEC
|
DANSEY ROGER D
|
Interim CEO & CMO
|
|
-5K
|
$154.41
|
-$774.98K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-3.6K
|
$154.41
|
-$553.41K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-3.6K
|
$154.41
|
-$563.29K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-1.1K
|
$154.41
|
-$174.95K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-4.2K
|
$154.41
|
-$646.36K
|
|
SEC
|
DANSEY ROGER D
|
Interim CEO & CMO
|
|
+40K
|
$14.81
|
+$597.89K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
+10K
|
$19.19
|
+$201.25K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
+12K
|
$18.15
|
+$219.47K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
+12K
|
$19.39
|
+$232.02K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
+13K
|
$19.23
|
+$259.22K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-712
|
$179.46
|
-$127.78K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-15K
|
$138.29
|
-$2.06M
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-11K
|
$136.79
|
-$1.49M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-333
|
$134.21
|
-$44.69K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-1.4K
|
$144.24
|
-$207.56K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-574
|
$144.32
|
-$82.84K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-401
|
$144.32
|
-$57.87K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-319
|
$144.32
|
-$46.04K
|
|
SEC
|
SIEGALL CLAY B
|
President & CEO
|
|
-1.9K
|
$144.32
|
-$272.04K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-567
|
$144.32
|
-$81.83K
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-4K
|
$143.95
|
-$575.80K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-17K
|
$154.23
|
-$2.63M
|
|
SEC
|
Baker Bros. Advisors (GP) LLC
|
N/A
|
|
+35K
|
$20.06
|
+$702.10K
|
|
SEC
|
Simonian Nancy A
|
N/A
|
|
+25K
|
$20.04
|
+$501.00K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-1.4K
|
$136.88
|
-$197.38K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-8.7K
|
$152.58
|
-$1.32M
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-560
|
$152.72
|
-$85.52K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-345
|
$149.85
|
-$51.70K
|
|
SEC
|
LIU JEAN I
|
Chief Legal Officer
|
|
-276
|
$149.85
|
-$41.36K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-1.3K
|
$149.85
|
-$198.25K
|
|
SEC
|
SIEGALL CLAY B
|
President & CEO
|
|
-1.2K
|
$149.85
|
-$183.87K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-345
|
$149.85
|
-$51.70K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
-395K
|
$160.54
|
-$63.40M
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
+1.6K
|
$46.37
|
+$74.98K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
+2.2K
|
$112.77
|
+$243.13K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
+2.2K
|
$46.37
|
+$99.97K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
+3.6K
|
$166.22
|
+$595.40K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
+201
|
$166.22
|
+$33.41K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Legal Affairs
|
|
+160
|
$166.22
|
+$26.60K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
+112
|
$166.22
|
+$18.62K
|
|
SEC
|
SIEGALL CLAY B
|
President & CEO
|
|
+714
|
$166.22
|
+$118.68K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
+201
|
$166.22
|
+$33.41K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-4.6K
|
$167.52
|
-$772.43K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-3.6K
|
$167.52
|
-$600.39K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Legal Affairs
|
|
-3.6K
|
$167.52
|
-$611.11K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-1.1K
|
$167.52
|
-$189.80K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-75K
|
$167.90
|
-$12.56M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-4K
|
$167.52
|
-$667.90K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
+16K
|
$13.60
|
+$211.00K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
+8.1K
|
$10.85
|
+$87.45K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
+8.5K
|
$11.14
|
+$95.00K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
+9.1K
|
$11.24
|
+$102.62K
|
|
SEC
|
SIEGALL CLAY B
|
President & CEO
|
|
+28K
|
$12.83
|
+$359.65K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
+11K
|
$7.08
|
+$74.78K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-10K
|
$156.59
|
-$1.57M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-703
|
$158.41
|
-$111.36K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-25K
|
$152.22
|
-$3.82M
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-87K
|
$17.46
|
-$1.52M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-334
|
$145.95
|
-$48.75K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
+38K
|
$17.61
|
+$665.73K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-1.1K
|
$140.00
|
-$148.54K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
+4.8K
|
$41.37
|
+$200.48K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-728
|
$163.97
|
-$119.37K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
+1.1K
|
$111.96
|
+$123.60K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
+1.6K
|
$104.74
|
+$170.10K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-60K
|
$13.05
|
-$788.34K
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-4.5K
|
$180.60
|
-$812.70K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-7.5K
|
$180.37
|
-$1.35M
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-7.7K
|
$177.00
|
-$1.36M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-14K
|
$180.37
|
-$2.54M
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
-79K
|
$127.81
|
-$10.14M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-14K
|
$136.49
|
-$1.89M
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
+10K
|
$36.77
|
+$366.01K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-12K
|
$170.00
|
-$1.97M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-16K
|
$155.82
|
-$2.54M
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-4.6K
|
$155.69
|
-$717.89K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-3.6K
|
$155.69
|
-$558.15K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-3.6K
|
$155.69
|
-$567.96K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-1.1K
|
$155.69
|
-$176.40K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-14K
|
$155.69
|
-$2.23M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
+10K
|
$19.42
|
+$200.01K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-8.1K
|
$158.17
|
-$1.27M
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-6.8K
|
$158.17
|
-$1.08M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-4K
|
$158.17
|
-$636.95K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-27K
|
$158.17
|
-$4.28M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-9.3K
|
$158.17
|
-$1.46M
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
+13K
|
$5.20
|
+$66.26K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-20K
|
$165.72
|
-$3.31M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-712
|
$167.49
|
-$119.25K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-12K
|
$167.58
|
-$1.94M
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-9.9K
|
$165.00
|
-$1.63M
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-2.2K
|
$158.89
|
-$343.52K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-5.8K
|
$157.15
|
-$914.93K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-1.7M
|
$159.76
|
-$279.15M
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-1.1M
|
$161.85
|
-$171.29M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-50K
|
$165.65
|
-$8.28M
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
-35K
|
$165.90
|
-$5.81M
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
-5.1K
|
$166.18
|
-$840.21K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
+12K
|
$79.52
|
+$969.51K
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
-1K
|
$152.03
|
-$152.03K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
+35K
|
$12.76
|
+$446.60K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
+9.6K
|
$13.64
|
+$130.59K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
+2.9K
|
$27.11
|
+$78.84K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
+9.6K
|
$27.11
|
+$259.04K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
+3.3K
|
$18.13
|
+$59.07K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Afairs
|
|
+2.1K
|
$26.71
|
+$55.80K
|
|
SEC
|
ROMP CHARLES R
|
EVP, Commercial
|
|
+1.9K
|
$18.16
|
+$33.78K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-350
|
$116.33
|
-$40.72K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-727
|
$108.51
|
-$78.89K
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
+18K
|
$12.76
|
+$223.30K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-2K
|
$114.07
|
-$228.14K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-7.4K
|
$86.00
|
-$639.15K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-15K
|
$85.00
|
-$1.28M
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-3K
|
$73.80
|
-$221.40K
|
|
SEC
|
DANSEY ROGER D
|
See Remarks
|
|
+29K
|
$2.15
|
+$61.39K
|
|
SEC
|
HIMES VAUGHN B
|
See Remarks
|
|
+12K
|
$27.25
|
+$335.75K
|
|
SEC
|
SIEGALL CLAY B
|
See Remarks
|
|
+38K
|
$11.89
|
+$455.87K
|
|
SEC
|
SIMPSON TODD E
|
See Remarks
|
|
+19K
|
$6.33
|
+$121.51K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-6.8K
|
$73.21
|
-$500.46K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-6K
|
$73.22
|
-$440.27K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-29K
|
$73.21
|
-$2.12M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-5.9K
|
$73.21
|
-$432.60K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-3.7K
|
$80.00
|
-$297.28K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-13K
|
$80.00
|
-$1.00M
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-3.7K
|
$75.00
|
-$278.70K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
+4.7K
|
$42.51
|
+$199.97K
|
|
SEC
|
DANSEY ROGER D
|
Chief Medical Officer
|
|
-5.4K
|
$68.60
|
-$371.54K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2.9K
|
$37.90
|
-$108.96K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
+20K
|
$8.38
|
+$167.60K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-13K
|
$78.00
|
-$975.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
+17K
|
$12.08
|
+$200.00K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-8K
|
$68.72
|
-$549.76K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-20K
|
$69.19
|
-$1.39M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-10K
|
$75.00
|
-$750.00K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-7K
|
$62.88
|
-$440.16K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-4.2K
|
$56.68
|
-$236.19K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
+5K
|
$8.38
|
+$41.90K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-4.8K
|
$74.23
|
-$355.12K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-5.5K
|
$74.23
|
-$410.49K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-4.1K
|
$74.23
|
-$306.05K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-26K
|
$74.23
|
-$1.89M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-5.4K
|
$74.23
|
-$402.85K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-25K
|
$74.95
|
-$1.87M
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
-7.4K
|
$69.25
|
-$512.45K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-2K
|
$50.84
|
-$100.05K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
+7.4K
|
$56.77
|
+$420.10K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
+461K
|
$53.34
|
+$24.57M
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-4K
|
$53.81
|
-$215.24K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
+1M
|
$50.45
|
+$51.46M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-19K
|
$50.52
|
-$951.39K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
+31K
|
$14.15
|
+$439.20K
|
|
SEC
|
WELCH DANIEL G
|
N/A
|
|
+17K
|
$9.39
|
+$158.51K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-1.4K
|
$55.58
|
-$77.76K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+3.8M
|
$52.00
|
+$200.00M
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
+19K
|
$11.06
|
+$214.74K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
+2.4K
|
$42.09
|
+$102.53K
|
|
SEC
|
LIU JEAN I
|
GC/EVP, Leg Affairs
|
|
-7.5K
|
$59.55
|
-$448.77K
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
-3K
|
$58.07
|
-$174.21K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-39K
|
$60.91
|
-$2.40M
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
+18K
|
$11.52
|
+$205.24K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
+9K
|
$11.09
|
+$100.00K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
+5K
|
$27.94
|
+$140.37K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-9.6K
|
$52.00
|
-$501.18K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-4.7K
|
$43.06
|
-$200.75K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-25K
|
$52.24
|
-$1.31M
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-1.8K
|
$47.89
|
-$85.63K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-5.3K
|
$47.89
|
-$255.88K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-8.5K
|
$47.89
|
-$407.16K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-6.4K
|
$47.89
|
-$305.39K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-26K
|
$47.89
|
-$1.22M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-4.9K
|
$47.89
|
-$236.43K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+7.4K
|
$66.60
|
+$492.84K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+20K
|
$10.20
|
+$204.00K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
+5K
|
$10.29
|
+$51.45K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2.4K
|
$64.26
|
-$154.22K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-10K
|
$63.38
|
-$633.80K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-13K
|
$65.92
|
-$824.00K
|
|
SEC
|
HIMES VAUGHN B
|
Chief Technical Officer
|
|
-30K
|
$65.32
|
-$1.96M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-14K
|
$66.17
|
-$957.15K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-7.8K
|
$66.75
|
-$517.38K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+383K
|
$59.36
|
+$22.71M
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
-1K
|
$57.75
|
-$57.75K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-14K
|
$58.43
|
-$845.19K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+1.2M
|
$56.13
|
+$68.99M
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-3.4K
|
$51.74
|
-$176.85K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-14K
|
$54.41
|
-$787.04K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-2.2K
|
$56.75
|
-$127.63K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-23K
|
$54.04
|
-$1.24M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+414K
|
$48.43
|
+$20.05M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-31K
|
$50.08
|
-$1.57M
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-5.4K
|
$46.01
|
-$248.32K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-12K
|
$45.40
|
-$529.05K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-13K
|
$48.00
|
-$604.27K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-1.8K
|
$46.59
|
-$82.65K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-5.4K
|
$46.59
|
-$252.10K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-4K
|
$46.59
|
-$185.94K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Proc Svcs & Tech Ops
|
|
-4K
|
$46.59
|
-$185.94K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-23K
|
$46.59
|
-$1.09M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-4K
|
$46.59
|
-$185.94K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-12K
|
$47.19
|
-$550.24K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-4K
|
$45.20
|
-$182.70K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-7.6K
|
$40.56
|
-$308.99K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-22K
|
$43.59
|
-$962.60K
|
|
SEC
|
Cline Darren S
|
EVP, Commercial
|
|
-3.4K
|
$42.07
|
-$141.61K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-49K
|
$40.41
|
-$1.97M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-8.4K
|
$40.09
|
-$336.76K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-7.6K
|
$35.16
|
-$267.85K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-800
|
$40.00
|
-$32.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-7.6K
|
$36.12
|
-$275.16K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-15K
|
$35.52
|
-$541.18K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+124K
|
$31.85
|
+$3.95M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+695K
|
$32.46
|
+$22.55M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+503K
|
$32.60
|
+$16.38M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+676K
|
$31.77
|
+$21.47M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+315K
|
$29.55
|
+$9.29M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+1M
|
$29.63
|
+$29.67M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+1.3M
|
$30.43
|
+$38.62M
|
|
SEC
|
Orwin John A
|
N/A
|
|
+2K
|
$28.33
|
+$56.66K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Proc Svcs & Tech Ops
|
|
-41K
|
$39.94
|
-$1.62M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-3.7K
|
$39.99
|
-$148.76K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+329K
|
$43.94
|
+$14.47M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-87K
|
$45.40
|
-$3.97M
|
|
SEC
|
Cline Darren S
|
SVP, Commercial
|
|
-5.8K
|
$45.68
|
-$263.53K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+935K
|
$42.95
|
+$40.14M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-17K
|
$42.50
|
-$741.71K
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-10K
|
$43.57
|
-$435.70K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-3.7K
|
$43.14
|
-$160.39K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-3.7K
|
$41.30
|
-$153.55K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+5.2M
|
$42.56
|
+$219.59M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-3.7K
|
$40.12
|
-$149.17K
|
|
SEC
|
Cline Darren S
|
SVP, Commercial
|
|
-4.5K
|
$42.02
|
-$187.49K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-17K
|
$42.02
|
-$718.37K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-4.5K
|
$42.02
|
-$187.49K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Proc Svcs & Tech Ops
|
|
-6K
|
$42.02
|
-$251.99K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-32K
|
$42.02
|
-$1.33M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-5.8K
|
$42.02
|
-$244.77K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-3.7K
|
$46.91
|
-$174.41K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-3.7K
|
$46.94
|
-$174.52K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-3.7K
|
$45.72
|
-$169.99K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+951K
|
$42.49
|
+$40.40M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-17K
|
$40.38
|
-$689.45K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-52K
|
$40.65
|
-$2.12M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+1M
|
$35.56
|
+$36.72M
|
|
SEC
|
Cline Darren S
|
SVP, Commercial
|
|
-7.5K
|
$38.65
|
-$289.88K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Proc Svcs & Tech Ops
|
|
-20K
|
$36.65
|
-$733.00K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+285K
|
$34.66
|
+$9.88M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+449K
|
$34.84
|
+$15.64M
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+281K
|
$33.92
|
+$9.54M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-17K
|
$31.80
|
-$534.37K
|
|
SEC
|
Baker Brothers Life Sciences LP
|
N/A
|
|
+2.9M
|
$31.86
|
+$91.86M
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+1.2M
|
$33.82
|
+$42.20M
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Tech. Ops. & Proc. Sci.
|
|
-10K
|
$37.52
|
-$375.20K
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+1.7M
|
$34.56
|
+$57.16M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-5.6K
|
$42.54
|
-$238.22K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-4.8K
|
$43.55
|
-$209.82K
|
|
SEC
|
BOERNER CHRISTOPHER S.
|
Executive Vice President, Comm
|
|
-1.2K
|
$43.55
|
-$54.35K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-2.8K
|
$43.55
|
-$120.72K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Tech. Ops. & Proc. Sci.
|
|
-3.3K
|
$43.55
|
-$144.15K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-26K
|
$43.55
|
-$1.11M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-3.7K
|
$43.55
|
-$160.96K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-11K
|
$40.38
|
-$452.26K
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+217K
|
$39.92
|
+$8.65M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-11K
|
$40.14
|
-$449.57K
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+546K
|
$38.16
|
+$20.84M
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+282K
|
$34.86
|
+$9.83M
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+190K
|
$34.07
|
+$6.46M
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Tech. Ops. & Proc. Sci.
|
|
-10K
|
$35.00
|
-$350.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-5.6K
|
$43.34
|
-$242.70K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-9.3K
|
$52.89
|
-$492.83K
|
|
SEC
|
BOERNER CHRISTOPHER S.
|
SVP, Commercial
|
|
-1.5K
|
$54.98
|
-$79.83K
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-1.2K
|
$53.25
|
-$66.08K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Tech, Ops. & Proc. Sci.
|
|
-5.1K
|
$52.01
|
-$264.63K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-100K
|
$51.97
|
-$5.20M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-56K
|
$47.92
|
-$2.68M
|
|
SEC
|
DRACHMAN JONATHAN G
|
CMO & EVP, R & D
|
|
-1.2K
|
$45.75
|
-$54.95K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-1.9K
|
$39.27
|
-$72.96K
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+407K
|
$39.66
|
+$16.14M
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+1M
|
$43.19
|
+$43.44M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$41.25
|
-$82.50K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$38.63
|
-$77.26K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$43.87
|
-$87.74K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-42K
|
$46.40
|
-$1.95M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-75K
|
$42.64
|
-$3.20M
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-10K
|
$42.48
|
-$424.80K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-102K
|
$43.90
|
-$4.48M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-38K
|
$41.45
|
-$1.57M
|
|
SEC
|
BOERNER CHRISTOPHER S.
|
SVP, Commercial
|
|
-226
|
$40.91
|
-$9.25K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-3.3K
|
$40.91
|
-$136.15K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Tech. Ops. & Proc. Sci.
|
|
-1.7K
|
$40.91
|
-$71.02K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-7.7K
|
$40.91
|
-$313.08K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-3.3K
|
$40.91
|
-$136.15K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$40.03
|
-$80.06K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$32.59
|
-$65.18K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-5K
|
$32.75
|
-$163.75K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Tech. Ops. & Proc. Sci.
|
|
-10K
|
$32.11
|
-$321.10K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$33.88
|
-$67.76K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-18K
|
$37.17
|
-$650.48K
|
|
SEC
|
14159, L.P.
|
N/A
|
|
+488K
|
$33.96
|
+$16.59M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$36.58
|
-$73.16K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$35.53
|
-$71.06K
|
|
SEC
|
BOERNER CHRISTOPHER S.
|
SVP, Commercial
|
|
-8.5K
|
$33.61
|
-$285.69K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-60K
|
$31.16
|
-$1.87M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-50K
|
$30.75
|
-$1.53M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-100K
|
$29.68
|
-$2.97M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-96K
|
$28.71
|
-$2.75M
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-10K
|
$27.17
|
-$271.70K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-2K
|
$29.61
|
-$59.22K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-125K
|
$28.00
|
-$3.50M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-51K
|
$24.95
|
-$1.27M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-8.2K
|
$24.13
|
-$199.05K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-50K
|
$23.70
|
-$1.19M
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-67K
|
$25.77
|
-$1.72M
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
-68K
|
$25.54
|
-$1.72M
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-40K
|
$25.59
|
-$1.02M
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-40K
|
$25.41
|
-$1.02M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-8.3K
|
$25.19
|
-$207.82K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-30K
|
$25.34
|
-$760.20K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-20K
|
$24.95
|
-$499.00K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-27K
|
$23.59
|
-$644.64K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-8.3K
|
$25.51
|
-$210.46K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-25K
|
$25.01
|
-$625.25K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-8.3K
|
$26.59
|
-$219.37K
|
|
SEC
|
HIMES VAUGHN B
|
EVP, Tech. Ops. & Proc. Sci.
|
|
-10K
|
$28.79
|
-$287.90K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-49K
|
$29.75
|
-$1.44M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-95K
|
$28.50
|
-$2.71M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-8.3K
|
$26.54
|
-$218.96K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-45K
|
$26.97
|
-$1.21M
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-40K
|
$25.97
|
-$1.04M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-25K
|
$24.01
|
-$600.25K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-8.3K
|
$26.00
|
-$214.50K
|
|
SEC
|
SIEGALL CLAY B
|
President & CEO
|
|
-8.3K
|
$25.36
|
-$209.22K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-25K
|
$25.36
|
-$634.00K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-95K
|
$24.50
|
-$2.33M
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-10K
|
$24.00
|
-$240.00K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-35K
|
$22.97
|
-$803.95K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-14K
|
$22.50
|
-$305.24K
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-8K
|
$19.75
|
-$158.00K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-65K
|
$21.54
|
-$1.40M
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-949
|
$19.75
|
-$18.74K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-25K
|
$19.95
|
-$498.75K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-40K
|
$19.75
|
-$790.00K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-38K
|
$19.51
|
-$746.86K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-44K
|
$18.88
|
-$834.85K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-40K
|
$19.78
|
-$791.20K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-40K
|
$19.75
|
-$790.00K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-70K
|
$18.59
|
-$1.29M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-46K
|
$18.52
|
-$851.92K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-40K
|
$19.75
|
-$790.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-15K
|
$16.73
|
-$250.95K
|
|
SEC
|
GRYSKA DAVID W
|
N/A
|
|
-10K
|
$18.09
|
-$180.90K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-15K
|
$15.97
|
-$239.55K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-15K
|
$21.89
|
-$328.35K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-21K
|
$21.95
|
-$459.15K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-20K
|
$20.58
|
-$421.09K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-24K
|
$21.97
|
-$534.97K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-15K
|
$20.15
|
-$302.25K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-30K
|
$20.12
|
-$603.60K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+131K
|
$17.08
|
+$2.24M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+1.2M
|
$15.38
|
+$18.20M
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-1.5K
|
$17.37
|
-$26.73K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-15K
|
$20.66
|
-$309.90K
|
|
SEC
|
BERGER FRANKLIN M
|
N/A
|
|
+7K
|
$20.04
|
+$140.28K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Operating Officer
|
|
-13K
|
$20.00
|
-$267.70K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-9K
|
$20.01
|
-$180.09K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-3.6K
|
$20.00
|
-$72.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-1K
|
$20.00
|
-$20.00K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-2.5K
|
$19.67
|
-$49.23K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-11K
|
$19.96
|
-$214.57K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-17K
|
$19.50
|
-$341.19K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-20K
|
$18.71
|
-$374.16K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-20K
|
$18.80
|
-$376.00K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-21K
|
$18.64
|
-$396.10K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-43K
|
$18.00
|
-$768.87K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-20K
|
$17.80
|
-$356.00K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-20K
|
$17.80
|
-$356.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-50K
|
$17.35
|
-$867.50K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-20K
|
$17.74
|
-$354.80K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-25K
|
$17.15
|
-$428.75K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-50K
|
$17.43
|
-$871.50K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-12K
|
$16.95
|
-$201.96K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-15K
|
$16.94
|
-$254.10K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-50K
|
$16.06
|
-$803.00K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-40K
|
$16.00
|
-$640.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-200K
|
$14.09
|
-$2.82M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+1.8M
|
$15.50
|
+$27.90M
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-25K
|
$16.22
|
-$405.50K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-25K
|
$15.81
|
-$395.25K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Process Sciences
|
|
-25K
|
$14.70
|
-$367.50K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-25K
|
$16.95
|
-$423.75K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-25K
|
$14.95
|
-$373.75K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+616K
|
$11.94
|
+$7.35M
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
+20K
|
$12.49
|
+$249.80K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+5.6K
|
$11.95
|
+$66.51K
|
|
SEC
|
BERGER FRANKLIN M
|
N/A
|
|
+5K
|
$13.37
|
+$66.85K
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
+11K
|
$11.92
|
+$132.01K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+577K
|
$12.79
|
+$7.38M
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-25K
|
$12.95
|
-$323.75K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+1.9M
|
$11.06
|
+$21.24M
|
|
SEC
|
BERGER FRANKLIN M
|
N/A
|
|
+12K
|
$12.05
|
+$138.58K
|
|
SEC
|
BERGER FRANKLIN M
|
N/A
|
|
+13K
|
$11.90
|
+$154.70K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
+4.9K
|
$11.47
|
+$56.26K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+274K
|
$10.75
|
+$2.95M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-60K
|
$12.36
|
-$741.60K
|
|
SEC
|
Reynolds Thomas C
|
Chief Medical Officer
|
|
-25K
|
$12.47
|
-$311.75K
|
|
SEC
|
ROSENBERG MORRIS
|
EVP, Development
|
|
-25K
|
$11.81
|
-$295.25K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
+5.5K
|
$9.21
|
+$50.66K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+1.2M
|
$9.72
|
+$11.45M
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-24K
|
$11.53
|
-$281.64K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-19K
|
$12.79
|
-$237.91K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-37K
|
$12.74
|
-$471.52K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-21K
|
$12.71
|
-$264.86K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-30K
|
$12.25
|
-$367.50K
|
|
SEC
|
ROSENBERG MORRIS
|
Sr. VP, Development
|
|
-50K
|
$11.30
|
-$565.00K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-96K
|
$10.85
|
-$1.04M
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-21K
|
$10.36
|
-$219.96K
|
|
SEC
|
H&Q Employee Venture Fund 2000, L.P.
|
N/A
|
|
-22K
|
$10.36
|
-$222.74K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-148K
|
$10.81
|
-$1.60M
|
|
SEC
|
H&Q Employee Venture Fund 2000, L.P.
|
N/A
|
|
-150K
|
$10.81
|
-$1.62M
|
|
SEC
|
JPMP GLOBAL INVESTORS L P
|
N/A
|
|
-172K
|
$10.36
|
-$1.78M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-100K
|
$10.78
|
-$1.08M
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-42K
|
$10.39
|
-$436.99K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-99K
|
$10.14
|
-$1.00M
|
|
SEC
|
JP MORGAN PARTNERS BHCA LP
|
N/A
|
|
-100K
|
$10.14
|
-$1.01M
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-121K
|
$10.10
|
-$1.23M
|
|
SEC
|
H&Q Employee Venture Fund 2000, L.P.
|
N/A
|
|
-123K
|
$10.10
|
-$1.24M
|
|
SEC
|
JPMP GLOBAL INVESTORS L P
|
N/A
|
|
-123K
|
$10.10
|
-$1.24M
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-51K
|
$10.06
|
-$512.01K
|
|
SEC
|
H&Q Employee Venture Fund 2000, L.P.
|
N/A
|
|
-52K
|
$10.06
|
-$518.45K
|
|
SEC
|
JPMP GLOBAL INVESTORS L P
|
N/A
|
|
-52K
|
$10.06
|
-$518.45K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+169K
|
$7.90
|
+$1.34M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+246K
|
$8.04
|
+$1.98M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+195K
|
$9.01
|
+$1.75M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+2.2M
|
$8.99
|
+$19.86M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+579K
|
$8.99
|
+$5.20M
|
|
SEC
|
BERGER FRANKLIN M
|
N/A
|
|
+528
|
$9.12
|
+$4.82K
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-21K
|
$12.63
|
-$264.72K
|
|
SEC
|
JP MORGAN PARTNERS BHCA LP
|
N/A
|
|
-21K
|
$12.63
|
-$268.06K
|
|
SEC
|
ROSENBERG MORRIS
|
Sr. VP, Development
|
|
-15K
|
$11.93
|
-$178.95K
|
|
SEC
|
SIMPSON TODD E
|
Chief Financial Officer
|
|
-32K
|
$11.91
|
-$384.10K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-56K
|
$11.80
|
-$656.08K
|
|
SEC
|
DOBMEIER ERIC
|
Chief Business Officer
|
|
-44K
|
$11.54
|
-$512.38K
|
|
SEC
|
LIPPMAN MARC E
|
N/A
|
|
+2K
|
$10.62
|
+$21.24K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-74K
|
$11.09
|
-$820.66K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-176K
|
$11.14
|
-$1.96M
|
|
SEC
|
ROSENBERG MORRIS
|
Sr. VP, Development
|
|
-25K
|
$10.32
|
-$258.00K
|
|
SEC
|
TrailSmith Pamela A
|
Chief Scientific Officer
|
|
-60K
|
$10.23
|
-$612.68K
|
|
SEC
|
ROSENBERG MORRIS
|
Sr. VP, Development
|
|
-25K
|
$9.54
|
-$238.50K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
-2.9M
|
$8.72
|
-$25.04M
|
|
SEC
|
AKKARAJU SRINIVAS
|
N/A
|
|
-2M
|
$8.57
|
-$17.27M
|
|
SEC
|
DOBMEIER ERIC
|
Sr. VP, Corporate Development
|
|
-50K
|
$8.94
|
-$447.00K
|
|
SEC
|
JPMP GLOBAL INVESTORS L P
|
N/A
|
|
-2M
|
$8.57
|
-$17.27M
|
|
SEC
|
GALLEN JONATHAN
|
N/A
|
|
-175K
|
$9.23
|
-$1.62M
|
|
SEC
|
GALLEN JONATHAN
|
N/A
|
|
-25K
|
$5.22
|
-$130.50K
|
|
SEC
|
GALLEN JONATHAN
|
N/A
|
|
-300K
|
$5.70
|
-$1.71M
|
|
SEC
|
GALLEN JONATHAN
|
N/A
|
|
-150K
|
$5.52
|
-$828.00K
|
|
SEC
|
GALLEN JONATHAN
|
N/A
|
|
-71K
|
$4.95
|
-$352.22K
|
|
SEC
|
GALLEN JONATHAN
|
N/A
|
|
-18K
|
$4.95
|
-$87.34K
|
|
SEC
|
GALLEN JONATHAN
|
N/A
|
|
-11K
|
$4.98
|
-$55.78K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+50K
|
$4.05
|
+$202.50K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+149K
|
$4.03
|
+$599.12K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+273K
|
$4.05
|
+$1.11M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+67K
|
$4.03
|
+$268.04K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+32K
|
$3.70
|
+$117.66K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+531K
|
$4.03
|
+$2.14M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+207K
|
$4.02
|
+$831.23K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+156K
|
$4.02
|
+$628.85K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+2.1M
|
$4.00
|
+$8.30M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+1.1M
|
$5.25
|
+$5.93M
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-73K
|
$5.97
|
-$435.81K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-24K
|
$5.99
|
-$143.76K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-103K
|
$5.96
|
-$613.88K
|
|
SEC
|
CARROLL TIM
|
CFO
|
|
-87K
|
$5.00
|
-$432.50K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+25K
|
$4.79
|
+$119.75K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+307K
|
$4.00
|
+$1.23M
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+40K
|
$4.96
|
+$198.90K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+34K
|
$4.88
|
+$166.97K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+469K
|
$4.99
|
+$2.34M
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-57K
|
$7.00
|
-$395.50K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-22K
|
$7.03
|
-$157.82K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-135K
|
$7.06
|
-$953.10K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-33K
|
$6.94
|
-$225.55K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-54K
|
$6.90
|
-$372.60K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-146K
|
$6.77
|
-$988.42K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-50K
|
$6.67
|
-$333.50K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-10K
|
$6.92
|
-$69.20K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-94K
|
$6.83
|
-$645.35K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-56K
|
$6.71
|
-$372.41K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-26K
|
$6.61
|
-$171.86K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-35K
|
$6.81
|
-$238.35K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-121K
|
$6.81
|
-$824.01K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-44K
|
$6.75
|
-$297.00K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+96K
|
$5.55
|
+$533.45K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+47K
|
$5.53
|
+$259.00K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+87K
|
$5.72
|
+$498.85K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-29K
|
$7.03
|
-$200.36K
|
|
SEC
|
CARROLL TIM
|
CFO
|
|
-60K
|
$7.04
|
-$422.40K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-122K
|
$7.08
|
-$860.22K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-80K
|
$7.12
|
-$569.60K
|
|
SEC
|
CARROLL TIM
|
CFO
|
|
-8.6K
|
$8.22
|
-$70.69K
|
|
SEC
|
DOBMEIER ERIC
|
V. P., Corporate Affairs
|
|
-15K
|
$8.59
|
-$128.85K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-65K
|
$10.42
|
-$677.30K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-7K
|
$8.90
|
-$62.30K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-87K
|
$7.22
|
-$629.95K
|
|
SEC
|
FELL H PERRY
|
Chairman
|
|
-50K
|
$6.47
|
-$323.50K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-153K
|
$6.33
|
-$968.49K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-50K
|
$6.47
|
-$323.50K
|
|
SEC
|
FELL H PERRY
|
Chairman
|
|
-4.5K
|
$6.44
|
-$28.98K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-109K
|
$6.27
|
-$680.30K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-4.5K
|
$6.44
|
-$28.98K
|
|
SEC
|
FELL H PERRY
|
Chairman
|
|
-57K
|
$6.52
|
-$368.38K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-57K
|
$6.52
|
-$368.38K
|
|
SEC
|
HELLSTROM KARL ERIK
|
N/A
|
|
-67K
|
$6.69
|
-$444.89K
|
|
SEC
|
HELLSTROM KARL ERIK
|
N/A
|
|
-134K
|
$6.48
|
-$865.08K
|
|
SEC
|
POWELL MICHAEL
|
N/A
|
|
-414K
|
$6.00
|
-$2.49M
|
|
SEC
|
FELL H PERRY
|
Chairman
|
|
-10K
|
$5.90
|
-$59.00K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-10K
|
$5.90
|
-$59.00K
|
|
SEC
|
FELL H PERRY
|
Chairman
|
|
-48K
|
$6.05
|
-$287.38K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-48K
|
$6.05
|
-$287.38K
|
|
SEC
|
FELL H PERRY
|
Chairman
|
|
-32K
|
$6.18
|
-$194.67K
|
|
SEC
|
SIEGALL CLAY B
|
President and CEO
|
|
-32K
|
$6.18
|
-$194.67K
|
|
SEC
|
SENTER PETER
|
Vice President, Chemistry
|
|
-20K
|
$5.27
|
-$103.29K
|
|
SEC
|
SING AMY
|
Sr. Director Medical Affairs
|
|
-20K
|
$5.09
|
-$101.80K
|
|
SEC
|
SING AMY
|
Sr. Director Medical Affairs
|
|
-5K
|
$4.70
|
-$23.50K
|
|